| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | PFE | Common Stock | 46K | Feb 23, 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Stock Appreciation Rights | Award | $0 | +103K | $0.00 | 103K | Feb 23, 2023 | Common Stock | 103K | $42.30 | Direct | F1 | |
| transaction | PFE | Stock Appreciation Rights | Award | $0 | +89.9K | $0.00 | 89.9K | Feb 23, 2023 | Common Stock | 89.9K | $42.30 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
| F2 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |